The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp625
MOVING TOWARDS WORK LIFE BALANCE: NEGOTIATING FOR THE JOB YOU WANT AND MODIFYING THE JOB YOU HAVE
Date
May 7, 2023
Explore related products in the following collection:
The proposed session entitled, Equity and Opportunity in Creating your New Normal in the GI Workforce will have three key areas of focus 1) to explore equity and opportunity in the new era of work life integration; 2) to identify negotiating styles and skills to promote work/life balance in clinical and research practices; and 3) to examine structural barriers in the field of gastroenterology during the pandemic and effective advocacy strategies.
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
The proposed session entitled, Equity and Opportunity in Creating your New Normal in the GI Workforce will have three key areas of focus 1) to explore equity and opportunity in the new era of work life integration; 2) to identify negotiating styles and skills to promote work/life balance in clinica…